Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Tianshengyuan-1 (TSY-1) regulates cellular Telomerase activity by methylation of TERT promoter.

Yu W, Qin X, Jin Y, Li Y, Santiskulvong C, Vu V, Zeng G, Zhang Z, Chow M, Rao J.

Oncotarget. 2017 Jan 31;8(5):7977-7988. doi: 10.18632/oncotarget.13939.

2.

Maternal HIV infection influences the microbiome of HIV-uninfected infants.

Bender JM, Li F, Martelly S, Byrt E, Rouzier V, Leo M, Tobin N, Pannaraj PS, Adisetiyo H, Rollie A, Santiskulvong C, Wang S, Autran C, Bode L, Fitzgerald D, Kuhn L, Aldrovandi GM.

Sci Transl Med. 2016 Jul 27;8(349):349ra100. doi: 10.1126/scitranslmed.aaf5103. Erratum in: Sci Transl Med. 2016 Aug 10;8(351):351er6.

3.

Screening cell mechanotype by parallel microfiltration.

Qi D, Kaur Gill N, Santiskulvong C, Sifuentes J, Dorigo O, Rao J, Taylor-Harding B, Ruprecht Wiedemeyer W, Rowat AC.

Sci Rep. 2015 Dec 2;5:17595. doi: 10.1038/srep17595.

4.

The role of Rho GTPase in cell stiffness and cisplatin resistance in ovarian cancer cells.

Sharma S, Santiskulvong C, Rao J, Gimzewski JK, Dorigo O.

Integr Biol (Camb). 2014 Jun;6(6):611-7. doi: 10.1039/c3ib40246k.

PMID:
24718685
5.

Effect of PI3K/Akt pathway inhibition-mediated G1 arrest on chemosensitization in ovarian cancer cells.

Fekete M, Santiskulvong C, Eng C, Dorigo O.

Anticancer Res. 2012 Feb;32(2):445-52.

PMID:
22287731
6.

Correlative nanomechanical profiling with super-resolution F-actin imaging reveals novel insights into mechanisms of cisplatin resistance in ovarian cancer cells.

Sharma S, Santiskulvong C, Bentolila LA, Rao J, Dorigo O, Gimzewski JK.

Nanomedicine. 2012 Jul;8(5):757-66. doi: 10.1016/j.nano.2011.09.015. Epub 2011 Oct 22.

PMID:
22024198
7.

Dual targeting of phosphoinositide 3-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma.

Santiskulvong C, Konecny GE, Fekete M, Chen KY, Karam A, Mulholland D, Eng C, Wu H, Song M, Dorigo O.

Clin Cancer Res. 2011 Apr 15;17(8):2373-84. doi: 10.1158/1078-0432.CCR-10-2289. Epub 2011 Mar 3.

8.

Cisplatin and PI3kinase inhibition decrease invasion and migration of human ovarian carcinoma cells and regulate matrix-metalloproteinase expression.

Karam AK, Santiskulvong C, Fekete M, Zabih S, Eng C, Dorigo O.

Cytoskeleton (Hoboken). 2010 Aug;67(8):535-44. doi: 10.1002/cm.20465.

9.

Protein kinase Calpha mediates feedback inhibition of EGF receptor transactivation induced by Gq-coupled receptor agonists.

Santiskulvong C, Rozengurt E.

Cell Signal. 2007 Jun;19(6):1348-57. Epub 2007 Jan 19.

PMID:
17307332
10.

EGF receptor transactivation mediates ANG II-stimulated mitogenesis in intestinal epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway.

Chiu T, Santiskulvong C, Rozengurt E.

Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G182-94. Epub 2004 Sep 9.

11.

Insulin reduces the requirement for EGFR transactivation in bombesin-induced DNA synthesis.

Santiskulvong C, Sinnett-Smith J, Rozengurt E.

Biochem Biophys Res Commun. 2004 Jun 11;318(4):826-32.

PMID:
15147945
13.

Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.

Guha S, Lunn JA, Santiskulvong C, Rozengurt E.

Cancer Res. 2003 May 15;63(10):2379-87.

14.

Rho and p38 MAP kinase signaling pathways mediate LPA-stimulated hepatic myofibroblast migration.

Tangkijvanich P, Melton AC, Santiskulvong C, Yee HF Jr.

J Biomed Sci. 2003 May-Jun;10(3):352-8.

PMID:
12711863
15.

ANG II stimulates PKC-dependent ERK activation, DNA synthesis, and cell division in intestinal epithelial cells.

Chiu T, Santiskulvong C, Rozengurt E.

Am J Physiol Gastrointest Liver Physiol. 2003 Jul;285(1):G1-11. Epub 2003 Mar 5.

16.

p38 MAP kinase mediates platelet-derived growth factor-stimulated migration of hepatic myofibroblasts.

Tangkijvanich P, Santiskulvong C, Melton AC, Rozengurt E, Yee HF Jr.

J Cell Physiol. 2002 Jun;191(3):351-61.

PMID:
12012331
17.

Vasopressin-mediated mitogenic signaling in intestinal epithelial cells.

Chiu T, Wu SS, Santiskulvong C, Tangkijvanich P, Yee HF Jr, Rozengurt E.

Am J Physiol Cell Physiol. 2002 Mar;282(3):C434-50.

18.

EGF receptor function is required in late G(1) for cell cycle progression induced by bombesin and bradykinin.

Santiskulvong C, Sinnett-Smith J, Rozengurt E.

Am J Physiol Cell Physiol. 2001 Sep;281(3):C886-98.

19.

Supplemental Content

Loading ...
Support Center